The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 13)
Diffusion Pharmaceuticals Reports Final Results From Phase 1b Study Of Trans Sodium Crocetinate In Hospitalized COVID-19 Patients
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) ("Diffusion" or the "Company"), an innovative biopharmaceutical company developing novel therapies that enhance the body's ability to
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers
Artelo Biosciences (NASDAQ:ARTL) stock rose 5.26% to $1.2 during Tuesday's after-market session. This security traded at a volume of 43.6K shares come close, making up 0.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $27.7 million.